Compare COST & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COST | JNJ |
|---|---|---|
| Founded | 1976 | 1886 |
| Country | United States | United States |
| Employees | 341000 | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.4B | 449.6B |
| IPO Year | 1993 | 1944 |
| Metric | COST | JNJ |
|---|---|---|
| Price | $852.98 | $205.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 15 |
| Target Price | ★ $1,051.30 | $206.93 |
| AVG Volume (30 Days) | 3.1M | ★ 9.4M |
| Earning Date | 12-11-2025 | 01-21-2026 |
| Dividend Yield | 0.61% | ★ 2.51% |
| EPS Growth | 9.70 | ★ 71.26 |
| EPS | ★ 18.67 | 10.35 |
| Revenue | ★ $280,391,000,000.00 | $92,149,000,000.00 |
| Revenue This Year | $9.99 | $6.60 |
| Revenue Next Year | $7.57 | $5.28 |
| P/E Ratio | $45.53 | ★ $20.03 |
| Revenue Growth | ★ 8.34 | 5.08 |
| 52 Week Low | $844.06 | $140.68 |
| 52 Week High | $1,078.24 | $215.19 |
| Indicator | COST | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 31.78 | 52.46 |
| Support Level | $844.06 | $199.91 |
| Resistance Level | $868.58 | $215.19 |
| Average True Range (ATR) | 14.77 | 3.87 |
| MACD | -2.76 | -0.71 |
| Stochastic Oscillator | 13.76 | 35.77 |
Founded in 1983, Costco Wholesale now operates a global chain of membership-based warehouse clubs, delivering high-quality goods and services at consistently low prices. As of its most recent fiscal year, Costco operated approximately 910 warehouses, serving more than 80 million members across its three geographic segments: Costco US (approximately 73% of total revenue), Costco Canada (13%), and Costco International (14%).Costco's core value proposition—quality products at unbeatable prices—has yielded consistently strong member renewal rates (93% in the US and Canada and nearly 90% internationally). About 55% of Costco's fiscal 2025 revenue came from its grocery offerings, and another 25% from general merchandise.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.